GT Biopharma, Inc. (GTBP) › Cost of RevenueGT Biopharma, Inc. (GTBP) — Cost of RevenueAnnual figures by period end, from SEC filings.2010-12-31: $65.0K2011-12-31: $48.0K2012-12-31: $94.0K2013-12-31: $226.0K2014-12-31: $57.0K2015-12-31: $02016-12-31: $02017-12-31: $0$02010-12-31Cost of Revenue (USD)2017-12-31Period endedCost of RevenueChange YoYSource filing2017-12-31$0—2018-03-01From 2017-01-012016-12-31$0—2018-03-01From 2016-01-012015-12-31$0-100.0%2018-02-28From 2015-01-012014-12-31$57.0K-74.8%2018-02-28From 2014-01-012013-12-31$226.0K+140.4%2015-03-31From 2013-01-012012-12-31$94.0K+95.8%2015-01-08From 2012-01-012011-12-31$48.0K-26.2%2014-11-18From 2011-01-012010-12-31$65.0K—2012-04-16From 2010-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)